Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Riley, Kathryn P.e; f | Jicha, Gregory A.c; e; f; * | Davis, Darong | Abner, Erin L.e; f | Cooper, Gregory E.c; e; f | Stiles, Nancye; f | Smith, Charles D.c; e; f | Kryscio, Richard J.b; e; f | Nelson, Peter T.d; e; f | Van Eldik, Linda J.a; e; f | Schmitt, Frederick A.c; e; f
Affiliations: [a] Department of Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, KY, USA | [b] Department of Biostatistics, University of Kentucky College of Medicine, Lexington, KY, USA | [c] Department of Neurology, University of Kentucky College of Medicine, Lexington, KY, USA | [d] Department of Pathology, University of Kentucky College of Medicine, Lexington, KY, USA | [e] Sanders-Brown Center on Aging, University of Kentucky College of Medicine, Lexington, KY, USA | [f] University of Kentucky Alzheimer's Disease Center, University of Kentucky College of Medicine, Lexington, KY, USA | [g] Central Baptist Hospital, Lexington, KY, USA
Correspondence: [*] Correspondence to: Gregory A. Jicha, M.D., Ph.D., Department of Neurology, Sanders-Brown Center on Aging, Room 223, 800 South Limestone Street, University of Kentucky College of Medicine, Lexington, KY 40536. Tel.: 859 257 1412 x255; Fax: 859 257 3819; E-mail: [email protected].
Abstract: Preclinical Alzheimer's disease (pAD) reflects neuropathological findings of AD in cognitively normal subjects. The present study represents an effort to determine if differences could be identified in the longitudinal patterns of cognitive performance in persons classified as pAD compared to those who did not meet criteria for AD at autopsy. We included 121 subjects who were cognitively normal from baseline through their last assessment before death and who underwent autopsy. Participants were classified into two groups: pathologically normal (PN; NIA-Reagan low or no-likelihood of AD, n = 89) and preclinical AD (pAD; NIA-Reagan criteria of intermediate or high-likelihood of AD in the absence of clinical dementia symptoms, n = 32) followed for a mean 7.5 years prior to death. Longitudinal rates and patterns of change in scores on a standard cognitive battery were compared between these two groups. While cognitive results at baseline and last evaluations revealed no clear cross sectional group differences after adjustment for age, ApoE status, education, and gender, statistically significant differences between the pAD and PN groups in slope of decline were seen on a composite score of cognitive function. Further analyses showed three components of this score reached significance: constructional praxis, delayed recall of a word list, and category verbal fluency. Despite being clinically viewed as normal at enrollment and at the final exam, there are significant differences in rates of cognitive decline in participants classified as pAD compared to those without this pathology. Longitudinal changes in slope of decline in specific cognitive test measures can serve as non-invasive methods for the detection of pAD.
Keywords: Alzheimer's disease, cognition, normal, preclinical
DOI: 10.3233/JAD-2011-102133
Journal: Journal of Alzheimer's Disease, vol. 25, no. 4, pp. 707-717, 2011
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]